Van T Vu, MD
Family Practice · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 1 carrier
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
10 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A152512 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,884
Medicare paid this office $1,884 for 28 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $125 | $9 |
Who their Medicare patients are
28 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Women 54% · Also on Medicaid 50% · Health risk score 0.94. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 39%.
The office billed $6,592, Medicare allowed $2,423 and paid $1,884; for 34 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 28 | 34 | 77 | 0.94 | $6,592 | $1,884 |
| 2023 | 14 | 14 | 77 | 1.16 | $1,302 | $167 |
| 2022 | 29 | 29 | 73 | 1.34 | $2,647 | $285 |
| 2021 | 22 | 22 | 76 | 1.13 | $894 | $163 |
| 2020 | 18 | 21 | 70 | 1.09 | $1,150 | $503 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $167 | $12 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $285 | $10 |
2021: 1 service
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 21 | $158 | $8 |
Medicaid work
$449,591 in 2024
Medicaid paid $449,591 for 4,851 billed services this clinician did in 2024, up to 212 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,563 | $446,783 |
| Return visit (30+ min) | 1,457 | $1,678 |
| Short return visit (20+ min) | 1,280 | $1,131 |
| Hemoglobin A1C level | 312 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 239 | $0 |
| 2024 | 4,851 | 5 | 212 | $449,591 |
| 2023 | 3,668 | 8 | 175 | $332,507 |
| 2022 | 5,543 | 11 | 201 | $485,423 |
| 2021 | 6,756 | 9 | 214 | $657,504 |
| 2020 | 6,477 | 10 | 217 | $653,046 |
| 2019 | 1,651 | 4 | 160 | $121,807 |
| 2018 | 176 | 1 | 34 | $0 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,177 | $331,237 |
| Short return visit (20+ min) | 1,543 | $860 |
| Return visit (30+ min) | 376 | $395 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 29 | $10 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 132 | $5 |
| Hemoglobin A1C level | 215 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 58 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 138 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,767 | $484,149 |
| Short return visit (20+ min) | 3,005 | $753 |
| Return visit (30+ min) | 310 | $307 |
| Short return visit | 50 | $214 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | 17 | $0 |
| Hemoglobin A1C level | 91 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 123 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 68 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 48 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use | 17 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 47 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,423 | $655,383 |
| Short return visit (20+ min) | 3,221 | $1,355 |
| Return visit (30+ min) | 584 | $409 |
| New patient visit (30+ min) | 120 | $358 |
| Hemoglobin A1C level | 44 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 162 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 152 | $0 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 26 | $0 |
| Short return visit | 24 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,450 | $651,624 |
| Short return visit (20+ min) | 3,171 | $1,206 |
| Short return visit | 568 | $113 |
| New patient visit (30+ min) | 54 | $72 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 61 | $25 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 91 | $5 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 23 | $2 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 20 | $0 |
| OFF/OP EST MAY X REQ PHY/QHP | 14 | $0 |
| Return visit (30+ min) | 25 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 458 | $121,528 |
| Short return visit (20+ min) | 960 | $216 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 112 | $48 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 121 | $15 |
2018
| Short return visit (20+ min) | 176 | $0 |
Drugs they prescribed that Part D paid
$207,186
Pharmacies billed $207,186 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,689 generic and fewer than 11 brand-name prescriptions · $207,186 in drug cost · 17 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 27 | $46,646 | $1,728 |
| Eliquis | 18 | $28,530 | $1,585 |
| Jardiance | 14 | $17,911 | $1,279 |
| Tradjenta | 11 | $14,248 | $1,295 |
| Januvia | 12 | $14,042 | $1,170 |
See all 38 drugs
| Vemlidy | 27 | $46,646 | $1,728 |
| Eliquis | 18 | $28,530 | $1,585 |
| Jardiance | 14 | $17,911 | $1,279 |
| Tradjenta | 11 | $14,248 | $1,295 |
| Januvia | 12 | $14,042 | $1,170 |
| Lidocaine | 26 | $4,806 | $185 |
| Atorvastatin | 284 | $2,366 | $8 |
| Losartan | 146 | $1,583 | $11 |
| Gabapentin | 61 | $1,426 | $23 |
| Albuterol Sulfate Hfa | 42 | $1,173 | $28 |
| Fluticasone-Salmeterol | 11 | $1,121 | $102 |
| Tamsulosin | 46 | $1,045 | $23 |
| Colchicine | 12 | $855 | $71 |
| Metformin | 83 | $776 | $9 |
| Fluticasone Propionate | 62 | $738 | $12 |
| Ventolin Hfa | 12 | $670 | $56 |
| Famotidine | 54 | $656 | $12 |
| Amlodipine Besylate | 134 | $618 | $5 |
| Alendronate | 64 | $479 | $7 |
| Diclofenac | 16 | $440 | $27 |
| Metoprolol | 28 | $368 | $13 |
| Omeprazole | 24 | $350 | $15 |
| Glipizide | 23 | $330 | $14 |
| Duloxetine | 12 | $314 | $26 |
| Glipizide Er | 20 | $298 | $15 |
| Lisinopril | 62 | $282 | $5 |
| Finasteride | 25 | $274 | $11 |
| Allopurinol | 14 | $206 | $15 |
| Levothyroxine | 18 | $204 | $11 |
| Triamcinolone Acetonide | 29 | $170 | $6 |
| Carvedilol | 19 | $142 | $7 |
| Hydrocortisone | 19 | $133 | $7 |
| Montelukast | 14 | $122 | $9 |
| Hydralazine | 11 | $119 | $11 |
| Simvastatin | 14 | $104 | $7 |
| Hydrochlorothiazide | 18 | $80 | $4 |
| Meclizine | 17 | $57 | $3 |
| Naproxen | 12 | $47 | $4 |
Year by year
| 2024 | 1,944 | 264 | None | None | $207,186 |
| 2023 | 1,379 | 182 | None | 13% | $166,507 |
| 2022 | 1,635 | 251 | None | 13% | $191,744 |
| 2021 | 1,612 | 237 | 1% (13) | 13% | $155,260 |
| 2020 | 1,258 | 258 | 1% (16) | None | $113,153 |
| 2019 | 490 | 128 | None | None | $24,526 |
| 2018 | 215 | 52 | 0% (0) | 13% | $13,966 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Vemlidy | 17 | $26,010 | $1,530 |
| Eliquis | 20 | $19,716 | $986 |
| Atorvastatin | 196 | $6,449 | $33 |
| Advair Diskus | 12 | $5,512 | $459 |
| Incruse Ellipta | 11 | $4,209 | $383 |
| Losartan | 101 | $2,792 | $28 |
| Lidocaine | 12 | $2,101 | $175 |
| Amlodipine Besylate | 78 | $1,820 | $23 |
| Alendronate | 56 | $1,640 | $29 |
| Gabapentin | 35 | $1,411 | $40 |
| Tamsulosin | 31 | $1,358 | $44 |
| Metformin | 59 | $1,342 | $23 |
| Lisinopril | 55 | $1,292 | $23 |
| Famotidine | 32 | $1,066 | $33 |
| Ventolin Hfa | 17 | $1,055 | $62 |
| Diclofenac | 23 | $965 | $42 |
| Glipizide Er | 20 | $736 | $37 |
| Levothyroxine | 21 | $736 | $35 |
| Omeprazole | 21 | $732 | $35 |
| Albuterol Sulfate Hfa | 19 | $650 | $34 |
| Fluticasone Propionate | 35 | $639 | $18 |
| Metoprolol | 16 | $562 | $35 |
| Carvedilol | 16 | $427 | $27 |
| Simvastatin | 11 | $308 | $28 |
| Finasteride | 11 | $282 | $26 |
| Glipizide | 12 | $259 | $22 |
| Trazodone | 13 | $226 | $17 |
| Triamcinolone Acetonide | 19 | $210 | $11 |
| Hydrochlorothiazide | 18 | $188 | $10 |
| Donepezil | 12 | $131 | $11 |
2022: 36 drugs
| Vemlidy | 25 | $34,872 | $1,395 |
| Eliquis | 13 | $20,140 | $1,549 |
| Jardiance | 11 | $18,725 | $1,702 |
| Tradjenta | 11 | $12,742 | $1,158 |
| Advair Diskus | 20 | $8,396 | $420 |
| Atorvastatin | 227 | $4,397 | $19 |
| Losartan | 126 | $1,918 | $15 |
| Diclofenac | 49 | $1,563 | $32 |
| Amlodipine Besylate | 86 | $1,201 | $14 |
| Metformin | 79 | $1,027 | $13 |
| Gabapentin | 46 | $963 | $21 |
| Famotidine | 50 | $959 | $19 |
| Albuterol Sulfate Hfa | 21 | $923 | $44 |
| Alendronate | 42 | $745 | $18 |
| Glipizide Er | 32 | $669 | $21 |
| Tamsulosin | 23 | $584 | $25 |
| Lisinopril | 46 | $576 | $13 |
| Levothyroxine | 21 | $538 | $26 |
| Trazodone | 14 | $391 | $28 |
| Mirtazapine | 12 | $379 | $32 |
| Allopurinol | 12 | $341 | $28 |
| Omeprazole | 14 | $339 | $24 |
| Metoprolol | 15 | $330 | $22 |
| Carvedilol | 16 | $327 | $20 |
| Fluticasone Propionate | 35 | $322 | $9 |
| Hydralazine | 14 | $301 | $21 |
| Sertraline | 13 | $278 | $21 |
| Glipizide | 15 | $230 | $15 |
| Hydrochlorothiazide | 26 | $205 | $8 |
| Triamcinolone Acetonide | 28 | $193 | $7 |
| Simvastatin | 13 | $158 | $12 |
| Hydrocortisone | 11 | $102 | $9 |
| Ibuprofen | 20 | $101 | $5 |
| Lorazepam | 12 | $72 | $6 |
| Atenolol | 13 | $57 | $4 |
| Meclizine | 11 | $56 | $5 |
2021: 34 drugs
| Vemlidy | 24 | $31,059 | $1,294 |
| Januvia | 22 | $29,195 | $1,327 |
| Jardiance | 15 | $15,032 | $1,002 |
| Lantus Solostar | 11 | $4,869 | $443 |
| Symbicort | 12 | $4,716 | $393 |
| Atorvastatin | 235 | $3,480 | $15 |
| Diclofenac | 64 | $1,611 | $25 |
| Losartan | 102 | $1,303 | $13 |
| Famotidine | 53 | $1,202 | $23 |
| Albuterol Sulfate Hfa | 22 | $1,071 | $49 |
| Ventolin Hfa | 17 | $841 | $49 |
| Metformin | 90 | $749 | $8 |
| Amlodipine Besylate | 87 | $717 | $8 |
| Glipizide Er | 34 | $609 | $18 |
| Gabapentin | 34 | $534 | $16 |
| Alendronate | 39 | $518 | $13 |
| Trazodone | 22 | $475 | $22 |
| Levothyroxine | 22 | $471 | $21 |
| Lisinopril | 73 | $450 | $6 |
| Fluticasone Propionate | 33 | $422 | $13 |
| Tamsulosin | 15 | $309 | $21 |
| Metoprolol | 12 | $297 | $25 |
| Carvedilol | 21 | $288 | $14 |
| Allopurinol | 12 | $273 | $23 |
| Sertraline | 18 | $249 | $14 |
| Montelukast | 11 | $245 | $22 |
| Triamcinolone Acetonide | 34 | $228 | $7 |
| Glipizide | 18 | $197 | $11 |
| Hydrochlorothiazide | 32 | $169 | $5 |
| Omeprazole | 16 | $156 | $10 |
| Simvastatin | 19 | $139 | $7 |
| Hydrocortisone | 24 | $121 | $5 |
| Naproxen | 12 | $58 | $5 |
| Ibuprofen | 11 | $56 | $5 |
2020: 30 drugs
| Januvia | 16 | $13,114 | $820 |
| Jardiance | 15 | $9,022 | $601 |
| Incruse Ellipta | 12 | $4,230 | $352 |
| Atorvastatin | 150 | $1,835 | $12 |
| Ventolin Hfa | 26 | $1,504 | $58 |
| Diclofenac | 49 | $1,036 | $21 |
| Famotidine | 62 | $893 | $14 |
| Losartan | 63 | $858 | $14 |
| Levothyroxine | 24 | $490 | $20 |
| Albuterol Sulfate Hfa | 11 | $485 | $44 |
| Metformin | 68 | $468 | $7 |
| Gabapentin | 34 | $376 | $11 |
| Fluticasone Propionate | 25 | $344 | $14 |
| Acetaminophen-Codeine | 11 | $296 | $27 |
| Quetiapine | 14 | $249 | $18 |
| Glipizide Er | 13 | $220 | $17 |
| Trazodone | 18 | $213 | $12 |
| Amlodipine Besylate | 46 | $207 | $5 |
| Hydrocortisone | 20 | $198 | $10 |
| Lisinopril | 46 | $193 | $4 |
| Glipizide | 22 | $162 | $7 |
| Alendronate | 28 | $158 | $6 |
| Omeprazole | 23 | $125 | $5 |
| Naproxen | 16 | $107 | $7 |
| Benazepril | 13 | $105 | $8 |
| Hydrochlorothiazide | 19 | $93 | $5 |
| Simvastatin | 15 | $85 | $6 |
| Allopurinol | 12 | $66 | $5 |
| Lorazepam | 13 | $65 | $5 |
| Triamcinolone Acetonide | 16 | $54 | $3 |
2019: 13 drugs
| Gabapentin | 11 | $1,907 | $173 |
| Ventolin Hfa | 12 | $693 | $58 |
| Atorvastatin | 35 | $608 | $17 |
| Levothyroxine | 11 | $273 | $25 |
| Metformin | 25 | $218 | $9 |
| Benazepril | 18 | $196 | $11 |
| Famotidine | 15 | $184 | $12 |
| Amlodipine Besylate | 28 | $177 | $6 |
| Losartan | 13 | $157 | $12 |
| Glipizide | 19 | $137 | $7 |
| Naproxen | 11 | $130 | $12 |
| Lisinopril | 22 | $129 | $6 |
| Fluticasone Propionate | 15 | $123 | $8 |
2018: 2 drugs
| Metformin | 13 | $147 | $11 |
| Amlodipine Besylate | 12 | $72 | $6 |
Professional record
- NPI
- 1003279068
- Licence
- CA A152512California A152512: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-03-29
- NPI last updated
- 2024-10-16
- NPI record certified
- 2024-10-16
This is when the NPI record was last certified, not a medical board exam.